- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2747EUR$3,000USD£2,339GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1832EUR$2,000USD£1,559GBP
- Report
- March 2025
- 150 Pages
Global
From €4442EUR$4,850USD£3,782GBP
- Report
- December 2024
- 200 Pages
Global
From €3434EUR$3,750USD£2,924GBP
- Report
- August 2024
- 140 Pages
Global
From €3617EUR$3,950USD£3,080GBP
- Report
- May 2024
- 140 Pages
Global
From €4532EUR$4,949USD£3,859GBP
- Report
- January 2025
- 53 Pages
Global
From €2289EUR$2,499USD£1,949GBP
- Report
- December 2024
- 51 Pages
Global
From €2289EUR$2,499USD£1,949GBP
- Report
- August 2024
- 41 Pages
Global
From €911EUR$995USD£776GBP
- Newsletter
- May 2025
Global
€2743EUR$2,995USD£2,335GBP
- Report
- July 2024
- 221 Pages
Global
From €4533EUR$4,950USD£3,860GBP
- Report
- January 2025
- 142 Pages
Asia Pacific
From €2976EUR$3,250USD£2,534GBP
- Report
- January 2025
- 134 Pages
Europe
From €3663EUR$4,000USD£3,119GBP
- Report
- October 2024
- 134 Pages
North America
From €3663EUR$4,000USD£3,119GBP
- Report
- July 2024
- 105 Pages
Asia Pacific
From €3160EUR$3,450USD£2,690GBP
- Report
- April 2022
- 400 Pages
Global
€1603EUR$1,750USD£1,365GBP
- Report
- August 2019
- 264 Pages
Global
From €3659EUR$3,995USD£3,115GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,105USD£1,586GBP
- Report
- November 2022
- 418 Pages
Global
From €2350EUR$2,749USD£2,071GBP
- Report
- March 2023
- 174 Pages
Global
From €1739EUR$1,899USD£1,481GBP

The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more